Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × Mitomycin × Clear all

Phase

Phase 3 7 Phase 2 6 Phase 2/3 1 Phase 1 1

Status

Terminated 2 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Anus Neoplasms 1

Interventions

Paclitaxel 9 Doxorubicin 8 Cyclophosphamide 8 Prednisone 7 Oxaliplatin 7 Docetaxel 7 Cisplatin 7 Capecitabine 6 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Etoposide 5 Carboplatin 5 pembrolizumab 4 Specimen Handling 4 Gemcitabine 4 Fluorouracil 4 Cytarabine 4 Bevacizumab 4 atezolizumab 3 Watchful Waiting 3 Vincristine 3 Trastuzumab 3 Taxes 3 Rituximab 3 Epirubicin 3 Dexamethasone 3 Calcium Dobesilate 3 venetoclax 2 toripalimab 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05902533 2025-12-18

REDEL

University of Cincinnati

Phase 2/3 Active not recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡